Purpose
Few biologic markers have been studied as prognostic factors in recurrent rectal carcinoma patients. We sought to determine the influence of clinical, pathologic, and biologic (p53, bcl-2, and ki-67) variables on survival after curative resection of locally recurrent rectal cancer.
Methods
Retrospective review of patients with locally recurrent rectal cancer who received surgery with curative intent.
Results
From 1988 to 1998, 134 patients with locally recurrent rectal cancer underwent operative exploration. Curative resection was performed in 85 patients. Median follow-up was 43 (range, 1.3–149) months. On multivariate analysis, negative predictors of overall survival included an elevated carcinoembryonic antigen level (P = 0.02; hazard ratio 2.41; 95 percent confidence interval, 1.19–4.89) and an R1 resection margin (P = 0.01; hazard ratio, 2.81; 95 percent confidence interval, 1.27–6.21). In 26 patients for whom biologic variables were available, p53, bcl-2, and ki-67 did not significantly impact disease-specific survival or overall survival. Five-year disease-specific survival, overall survival, and pelvic control rates were 46, 36, and 51 percent respectively. Of the 50 patients who relapsed, time to second local recurrence was longer than time to development of metastasis (median, 16.5 vs. 9 months). Median survival for patients with metastatic recurrence was 26.l vs. 41.5 months for those with a subsequent local recurrence alone.
Conclusions
Approximately two-thirds of patients with locally recurrent rectal cancer can be resected for cure. Preoperative carcinoembryonic antigen and an R0 resection margin were the only significant predictors of overall survival. p53, bcl-2, and ki-67 did not impact survival outcomes.
Similar content being viewed by others
References
InstitutionalAuthorNameAnonymous (1997) ArticleTitleImproved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 336 980–987 Occurrence Handle10.1056/NEJM199704033361402
E Kapiteijn CA Marijnen ID Nagtegaal et al. (2001) ArticleTitlePreoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638–646 Occurrence Handle10.1056/NEJMoa010580 Occurrence Handle1:STN:280:DC%2BD3Mvps1ektw%3D%3D Occurrence Handle11547717
TA Rich JM Skibber JA Ajani et al. (1995) ArticleTitlePreoperative infusional chemoradiation therapy for stage T3 rectal cancer Int J Radiat Oncol Biol Phys 32 1025–1029 Occurrence Handle1:STN:280:DyaK2Mzjt1SmsA%3D%3D Occurrence Handle7607922 Occurrence Handle10.1016/0360-3016(95)00020-Y
SJ Stryker KD Kiel A Rademaker JM Shaw GT Ujiki SM Poticha (1996) ArticleTitlePreoperative “chemoradiation” for stages II and III rectal carcinoma Arch Surg 131 514–518 Occurrence Handle1:STN:280:DyaK283gvFSjsw%3D%3D Occurrence Handle8624198
J Garcia-Aguilar E Hernandez de Anda P Sirivongs SR Lee RD Madoff DA Rothenberger (2003) ArticleTitleA pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 298–304 Occurrence Handle12626903 Occurrence Handle10.1007/s10350-004-6545-x
S Pucciarelli ML Friso P Toppan et al. (2000) ArticleTitlePreoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results Ann Surg Oncol 7 38–44 Occurrence Handle10.1007/s10434-000-0038-5 Occurrence Handle1:STN:280:DC%2BD3c7js12isA%3D%3D Occurrence Handle10674447
RS Chari DS Tyler MS Anscher et al. (1995) ArticleTitlePreoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Ann Surg 221 778–786 Occurrence Handle1:STN:280:DyaK2MzhsVChtw%3D%3D Occurrence Handle7794081
PM Sagar JR Pemberton (1996) ArticleTitleSurgical management of locally recurrent rectal cancer Br J Surg 83 293–304 Occurrence Handle1:STN:280:DyaK283ks1anug%3D%3D Occurrence Handle8665179
AM Lowy TA Rich JM Skibber RA Dubrow SA Curley (1996) ArticleTitlePreoperative infusional chemoradiation. Selective intraoperative radiation and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma Ann Surg 223 177–185 Occurrence Handle10.1097/00000658-199602000-00010 Occurrence Handle1:STN:280:DyaK287nsFeltQ%3D%3D Occurrence Handle8597512
CR Shumate TA Rich JM Skibber JA Ajani DM Ota (1993) ArticleTitlePreoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity Cancer 71 3690–3696 Occurrence Handle1:STN:280:DyaK3s3lvVOmsQ%3D%3D Occurrence Handle8490919
WL Law KW Chu (2000) ArticleTitleResection of local recurrence of rectal cancer: results World J Surg 24 486–490 Occurrence Handle10.1007/s002689910077 Occurrence Handle1:STN:280:DC%2BD3c7ntlyjsA%3D%3D Occurrence Handle10706924
LB Harrison BD Minsky WE Enker et al. (1998) ArticleTitleHigh dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer Int J Radiat Oncol Biol Phys 42 325–330 Occurrence Handle10.1016/S0360-3016(98)00211-9 Occurrence Handle1:STN:280:DyaK1M%2Fgt1Clsg%3D%3D Occurrence Handle9788411
K Suzuki RR Dozois RM Devine et al. (1996) ArticleTitleCurative reoperations for locally recurrent rectal cancer Dis Colon Rectum 39 730–736 Occurrence Handle10.1007/BF02054435 Occurrence Handle1:STN:280:DyaK283ptVGmug%3D%3D Occurrence Handle8674362
D Hahnloser H Nelson LL Gunderson et al. (2003) ArticleTitleCurative potential of multimodality therapy for locally recurrent rectal cancer Ann Surg 237 502–508 Occurrence Handle10.1097/00000658-200304000-00011 Occurrence Handle12677146
CG Willett PC Shellito JE Tepper R Eliseo K Convery WC Wood (1991) ArticleTitleIntraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma Cancer 67 1504–1508 Occurrence Handle1:STN:280:DyaK3M7lvF2itQ%3D%3D Occurrence Handle2001537
K Yamada T Ishizawa K Niwa Y Chuman S Akiha T Aikou (2001) ArticleTitlePatterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer Br J Surg 88 988–993 Occurrence Handle10.1046/j.0007-1323.2001.01811.x Occurrence Handle1:STN:280:DC%2BD3MzovVOrsg%3D%3D Occurrence Handle11442533
F Lopez-Kostner VW Fazio A Vignali LA Rybicki IC Lavery (2001) ArticleTitleLocally recurrent rectal cancer: predictors and success of salvage surgery Dis Colon Rectum 44 173–178 Occurrence Handle10.1007/BF02234289 Occurrence Handle1:STN:280:DC%2BD3M7ot1Sltg%3D%3D Occurrence Handle11227932
JC Salo PB Paty J Guillem BD Minsky LB Harrison AM Cohen (1999) ArticleTitleSurgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience Ann Surg Oncol 6 171–177 Occurrence Handle10.1007/s10434-999-0171-8 Occurrence Handle1:STN:280:DyaK1M7otVSrsg%3D%3D Occurrence Handle10082043
M Shoup JG Guillem KM Alektiar et al. (2002) ArticleTitlePredictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy Dis Colon Rectum 45 585–592 Occurrence Handle10.1007/s10350-004-6250-9 Occurrence Handle12004205
SH Meterissian JM Skibber GG Giacco AK el-Naggar KR Hess TA Rich (1997) ArticleTitlePelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival Surgery 121 479–487 Occurrence Handle10.1016/S0039-6060(97)90100-8 Occurrence Handle1:STN:280:DyaK2s3oslSmsA%3D%3D Occurrence Handle9142144
IO Baas JW Mulder GJ Offerhaus B Vogeistein SR Hamilton (1994) ArticleTitleAn evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 5–12 Occurrence Handle10.1002/path.1711720104 Occurrence Handle1:CAS:528:DyaK2cXmvFKnt7g%3D Occurrence Handle7931827
FR Spitz GG Giacco K Hess et al. (1997) ArticleTitlep53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer Clin Cancer Res 3 1685–1690 Occurrence Handle1:STN:280:DyaK1M7htFWjuw%3D%3D Occurrence Handle9815551
S Cascinu F Graziano V Catalano et al. (2002) ArticleTitleAn analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumor recurrence and event-free survival of patients treated with adjuvant chemoradiation Br JCancer 86 744–749 Occurrence Handle1:CAS:528:DC%2BD38XjtVKjsbo%3D Occurrence Handle10.1038/sj.bjc.6600155
O Schwandner TH Schiedeck HP Bruch M Duchrow U Windhoevel R Broil (2000) ArticleTitlep53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer Eur J Cancer 36 348–356 Occurrence Handle10.1016/S0959-8049(99)00271-3 Occurrence Handle1:CAS:528:DC%2BD3cXhsFOjs78%3D Occurrence Handle10708936
M Diez JM Enriquez J Carnunas et al. (1995) ArticleTitlePrediction of recurrence in B–C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features Eur J Surg Oncol 21 635–639 Occurrence Handle10.1016/S0748-7983(95)95477-5 Occurrence Handle1:STN:280:DyaK283isF2gtg%3D%3D Occurrence Handle8631411
S Buglioni I D'Agnano M Cosimelli et al. (1999) ArticleTitleEvaluation of multiple biopathological factors in colorectal adenocarcinornas: independent prognostic role of p53 and bcl-2 Int J Cancer 84 545–552 Occurrence Handle10.1002/(SICI)1097-0215(19991222)84:6<545::AID-IJC1>3.0.CO;2-2 Occurrence Handle1:CAS:528:DC%2BD3cXktFKq Occurrence Handle10567896
D Hockenbery G Nunez C Milliman RD Schreiher (1990) ArticleTitleKorsmeyer. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 334–336 Occurrence Handle10.1038/348334a0 Occurrence Handle1:CAS:528:DyaK3MXit1ehuw%3D%3D Occurrence Handle2250705
C Rodel GG Grabenhauer T Papadopoulos et al. (2002) ArticleTitleApoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Radiat Oncol Biol Phys 52 294–303 Occurrence Handle11872273 Occurrence Handle10.1016/S0360-3016(01)02643-8
NK Kim JK Park KY Lee et al. (2001) ArticleTitlep53, BCL-2, and Ki-67 expression according to tumor response after concurrent chernoradiotherapy for advanced rectal cancer Ann Surg Oncol 8 418–424 Occurrence Handle1:STN:280:DC%2BD3MzksVGhug%3D%3D Occurrence Handle11407516
T Wiggers GH Mannaerts AW Marinelli H Martijn HJ Rutten (2003) ArticleTitleSurgery for locally recurrent rectal cancer Colorectal Dis 5 504–507 Occurrence Handle10.1046/j.1463-1318.2003.00507.x Occurrence Handle1:STN:280:DC%2BD3szovVemsw%3D%3D Occurrence Handle12925090
J Garcia-Aguilar JW Cromwell C Marra SH Lee RD Madoff DA Rothenberger (2001) ArticleTitleTreatment of locally recurrent rectal cancer Dis Colon Rectum 44 1743–1748 Occurrence Handle10.1007/BF02234449 Occurrence Handle1:STN:280:DC%2BD3MjgtV2jsw%3D%3D Occurrence Handle11742153
B Rau I Sturm H Lage et al. (2003) ArticleTitleDynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy J Clin Oncol 21 3391–3401 Occurrence Handle10.1200/JCO.2003.07.077 Occurrence Handle1:CAS:528:DC%2BD2cXpsVKjtL0%3D Occurrence Handle12885834
B Glimelius (2003) ArticleTitleRecurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis 5 501–503 Occurrence Handle10.1046/j.1463-1318.2003.00501.x Occurrence Handle12925089
M Mohiuddin G Marks J Marks (2002) ArticleTitleLong-term results of reirradiation for patients with recurrent rectal carcinoma Cancer 95 1144–1150 Occurrence Handle10.1002/cncr.10799 Occurrence Handle12209702
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bedrosian, I., Giacco, G., Pederson, L. et al. Outcome After Curative Resection for Locally Recurrent Rectal Cancer. Dis Colon Rectum 49, 175–182 (2006). https://doi.org/10.1007/s10350-005-0276-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-005-0276-5